Ilana B. Richman, MD; Joseph S. Ross, MD, MHS
Financial Support: Dr. Richman is supported by the National Institutes of Health Clinical and Translational Science Awards KL2 Program (KL2TR001862).
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3066.
Corresponding Author: Joseph S. Ross, MD, MHS, Section of General Medicine, Department of Internal Medicine, Yale University School of Medicine, PO Box 208093, New Haven, CT 06520-8093; e-mail, email@example.com.
Current Author Addresses: Dr. Richman: Yale University School of Medicine, 367 Cedar Street, Harkness A, Room 301a, New Haven, CT 06511.
Dr. Ross: Section of General Medicine, Department of Internal Medicine, Yale University School of Medicine, PO Box 208093, New Haven, CT 06520-8093.
Richman IB, Ross JS. Weighing the Harms and Benefits of Using Statins for Primary Prevention: Raising the Risk Threshold. Ann Intern Med. 2019;170:62–63. [Epub ahead of print 4 December 2018]. doi: https://doi.org/10.7326/M18-3066
Download citation file:
Published: Ann Intern Med. 2019;170(1):62-63.
Published at www.annals.org on 4 December 2018
Cardiology, Coronary Risk Factors, Dyslipidemia, Prevention/Screening.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use